APA

Burzynski S. R., Weaver R. A., Janicki T., Szymkowski B., Jurida G., Khan M. & Dolgopolov V. (20050929). Long-term survival of high-risk pediatric patients with primitive neuroectodermal tumors treated with antineoplastons A10 and AS2-1. : Integrative cancer therapies.

Chicago

Burzynski Stanislaw R, Weaver Robert A, Janicki Tomasz, Szymkowski Barbara, Jurida Gabor, Khan Mohammad and Dolgopolov Vsevolod. 20050929. Long-term survival of high-risk pediatric patients with primitive neuroectodermal tumors treated with antineoplastons A10 and AS2-1. : Integrative cancer therapies.

Harvard

Burzynski S. R., Weaver R. A., Janicki T., Szymkowski B., Jurida G., Khan M. and Dolgopolov V. (20050929). Long-term survival of high-risk pediatric patients with primitive neuroectodermal tumors treated with antineoplastons A10 and AS2-1. : Integrative cancer therapies.

MLA

Burzynski Stanislaw R, Weaver Robert A, Janicki Tomasz, Szymkowski Barbara, Jurida Gabor, Khan Mohammad and Dolgopolov Vsevolod. Long-term survival of high-risk pediatric patients with primitive neuroectodermal tumors treated with antineoplastons A10 and AS2-1. : Integrative cancer therapies. 20050929.